Association between immunohistochemical markers and response after neoadjuvant chemotherapy in advanced breast cancer

被引：0
|
作者：
Lee, H. [1 ]
Lee, O. [1 ]
Son, S. [1 ]
Woo, C. G. [1 ]
机构：
[1] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Cheongju, South Korea
来源：
VIRCHOWS ARCHIV | 2024年 / 485卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
E-PS-02-05
引用
收藏
页码：S197 / S197
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant chemotherapy in locally advanced breast cancer
    Singh, G
    Singh, DP
    Gupta, D
    Muralikrishna, BV
    JOURNAL OF SURGICAL ONCOLOGY, 1996, 61 (01) : 38 - 41
  • [42] Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
    Iqbal, Javeria
    Shafi, Alam Ara
    Alharthi, Bandar N.
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2014, 24 (11): : 845 - 848
  • [43] Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
    Specht, Jennifer
    Gralow, Julie R.
    SEMINARS IN RADIATION ONCOLOGY, 2009, 19 (04) : 222 - 228
  • [44] Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
    McGuire, Andrew
    Casey, Maire-Caitlin
    Waldron, Ronan M.
    Heneghan, Helen
    Kalinina, Olga
    Holian, Emma
    McDermott, Ailbhe
    Lowery, Aoife J.
    Newell, John
    Dwyer, Roisin M.
    Miller, Nicola
    Keane, Maccon
    Brown, James A. L.
    Kerin, Michael J.
    CANCERS, 2020, 12 (07) : 1 - 12
  • [45] DNA methylation markers of breast cancer response to anthracycline based neoadjuvant chemotherapy
    Sigin, V. O.
    Strelnikov, V. V.
    Litviakov, N. V.
    Simonova, O. A.
    Volodin, V.
    Slonimskaya, E. M.
    Tanas, A. S.
    Zaletaev, D. V.
    Kuznetsova, E. B.
    Tsyganov, M. M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [46] Neoadjuvant chemotherapy for locally advanced breast cancer
    Fomenko, Y.
    Sirota, V.
    Bitz, U.
    Zhumakaeva, S.
    Omarova, I.
    Kabildina, N.
    ANNALS OF ONCOLOGY, 2016, 27
  • [47] NEW IMMUNOHISTOCHEMICAL MARKERS PREDICTIVE OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY PLUS TRASTUZUMAB IN HER2-POSITIVE LOCALLY ADVANCED BREAST CANCER: A SINGLE CENTER EXPERIENCE
    Faggioni, G.
    Ghiotto, C.
    Orvieto, E.
    Valpione, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 124 - 124
  • [48] Conversion of immunohistochemical markers and breast density are associated with pathological response and prognosis in very young breast cancer patients who fail to achieve a pathological complete response after neoadjuvant chemotherapy
    Zhao, Yue
    Wang, Xiaolei
    Huang, Yuanxi
    Zhou, Xianli
    Zhang, Dongwei
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 5677 - 5690
  • [49] Chemotherapy-induced amennorrhea: Predictive markers of response to neoadjuvant chemotherapy in breast cancer.
    Ko, E.
    Kim, J. S.
    You, J. M.
    Shin, H.
    Han, W.
    Nah, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [50] Can MRI Predict Pathologic Complete Response After Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer?
    Lee, C.
    Le-Tran, V.
    Olimpiadi, Y.
    Zaremba, N.
    Nelson, M.
    Lang, J. E.
    Sener, S. F.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S90 - S90
12345